Thank you for writing to the Division of Drug Information in the FDA's Center for Drug Evaluation and Research.
Unfortunately we do not have an update at this time. In February 2013, Affymax and Takeda Pharmaceuticals decided to voluntarily recall all lots of OMONTYS® (peginesatide) Injection to the user level as a result of new postmarketing reports regarding serious hypersensitivity reactions, including anaphylaxis, which can be life-threatening or fatal. You may find additional information at
Drug Information Specialist
Division of Drug Information
Center for Drug Evaluation and Research
Food and Drug Administration